Aging, components of metabolic syndrome and serum C-reactive protein showed significant relationship with carotid atherosclerosis

Aging Male

Volumn 15, Issue 1, 2012, Pages 42-47

  Kawada, Tomoyuki ^a   Otsuka, Toshiaki ^a   Endo, Tokiomi ^b   Kon, Yoichi ^b  

^a NIPPON MEDICAL SCHOOL   (Japan)

^b Ota General Hospital   (Japan)

Author keywords

Aging; Inflammatory marker; Intima media thickness; Metabolic components

Indexed keywords

C REACTIVE PROTEIN;

ADULT; AGED; AGING; ARTERIAL WALL THICKNESS; ARTICLE; CAROTID ATHEROSCLEROSIS; COMMON CAROTID ARTERY; FEMALE; GROUPS BY AGE; HUMAN; JAPANESE; MAJOR CLINICAL STUDY; MALE; METABOLIC SYNDROME X; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN FUNCTION; SEX DIFFERENCE;

ADULT; AGED; AGED, 80 AND OVER; AGING; C-REACTIVE PROTEIN; CAROTID ARTERY DISEASES; FEMALE; HUMANS; LIFE STYLE; MALE; METABOLIC SYNDROME X; MIDDLE AGED; SMOKING;

EID: 84856818642     PISSN: 13685538     EISSN: 14730790     Source Type: Journal    
DOI: 10.3109/13685538.2011.593656     Document Type: Article

References (34)

1. Zambon A, Pauletto P, Crepaldi G. Review article: The metabolic syndrome-a chronic cardiovascular inflammatory condition. Aliment Pharmacol Ther. 2005;22 Suppl 2:20-23. (Pubitemid 41564376)
2. Lorenzo C, Williams K, Hunt KJ, Haffner SM. The National Cholesterol Education Program - Adult Treatment Panel III, International Diabetes Federation, and World Health Organization definitions of the metabolic syndrome as predictors of incident cardiovascular disease and diabetes. Diabetes Care. 2007;30:8-13.
3. Mazza AD, Morley JE. Metabolic syndrome and the older male population. Aging Male. 2007;10:3-8. (Pubitemid 46440590)
4. Goncharov NP, Katsya GV, Chagina NA, Gooren LJ. Three definitions of metabolic syndrome applied to a sample of young obese men and their relation with plasma testosterone. Aging Male. 2008;11: 118-122.
5. Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults. Executive Summary of the Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). JAMA:2001:285:2486-2497.
6. Unwin N, Bhopal R, Hayes L, White M, Patel S, Ragoobirsingh D, Alberti G. A comparison of the new international diabetes federation definition of metabolic syndrome to WHO and NCEP definitions in Chinese, European and South Asian origin adults. Ethn Dis. 2007;17: 522-528. (Pubitemid 47606762)
7. Delavari A, Forouzanfar MH, Alikhani S, Sharifian A, Kelishadi R. First nationwide study of the prevalence of the metabolic syndrome and optimal cutoff points of waist circumference in the Middle East: The national survey of risk factors for noncommunicable diseases of Iran. Diabetes Care. 2009;32:1092-1097.
8. Bonora E, Kiechl S, Willeit J, Oberhollenzer F, Egger G, Bonadonna RC, Muggeo M; Bruneck study. Carotid atherosclerosis and coronary heart disease in the metabolic syndrome: Prospective data from the Bruneck study. Diabetes Care. 2003;26:1251-1257. (Pubitemid 36929281)
9. Staub D, Meyerhans A, Bundi B, Schmid HP, Frauchiger B. Prediction of cardiovascular morbidity and mortality: Comparison of the internal carotid artery resistive index with the common carotid artery intimamedia thickness. Stroke. 2006;37:800-805. (Pubitemid 43731912)
10. Johnsen SH, Mathiesen EB, Joakimsen O, Stensland E, Wilsgaard T, Løchen ML, Njølstad I, Arnesen E. Carotid atherosclerosis is a stronger predictor of myocardial infarction in women than in men: A 6-year follow-up study of 6226 persons: The Tromsø Study. Stroke. 2007;38:2873-2880. (Pubitemid 350035678)
11. Uthoff H, Staub D, Meyerhans A, Hochuli M, Bundi B, Schmid HP, Frauchiger B. Intima-media thickness and carotid resistive index: Progression over 6 years and predictive value for cardiovascular events. Ultraschall Med. 2008;29:604-610.
12. Lorenz MW, von Kegler S, Steinmetz H, Markus HS, Sitzer M. Carotid intima-media thickening indicates a higher vascular risk across a wide age range: Prospective data from the Carotid Atherosclerosis Progression Study (CAPS). Stroke. 2006;37:87-92. (Pubitemid 43732053)
13. Lorenz MW, Markus HS, Bots ML, Rosvall M, Sitzer M. Prediction of clinical cardiovascular events with carotid intima-media thickness: A systematic review and meta-analysis. Circulation. 2007;115: 459-467. (Pubitemid 46184197)
14. Willerson JT, Ridker PM. Inflammation as a cardiovascular risk factor. Circulation. 2004;109:II2-I10.
15. Koenig W. Predicting risk and treatment benefit in atherosclerosis: The role of C-reactive protein. Int J Cardiol. 2005;98:199-206. (Pubitemid 40431164)
16. Kampus P, Kals J, Ristimäe T, Muda P, Ulst K, Zilmer K, Salonen RM, Tuomainen TP, Teesalu R, Zilmer M. Augmentation index and carotid intima-media thickness are differently related to age, C-reactive protein and oxidized low-density lipoprotein. J Hypertens. 2007;25:819-825. (Pubitemid 46398877)
17. Thakore AH, Guo CY, Larson MG, Corey D, Wang TJ, Vasan RS, Dagostino RB Sr, Lipinska I, Keaney JF Jr, Benjamin EJ, ODonnell CJ. Association of multiple inflammatory markers with carotid intimal medial thickness and stenosis (from the Framingham Heart Study). Am J Cardiol. 2007;99:1598-1602. (Pubitemid 46773027)
18. Sander K, Horn CS, Briesenick C, Sander D; INVADE Study Group. High-sensitivity C-reactive protein is independently associated with early carotid artery progression in women but not in men: The INVADE Study. Stroke. 2007;38:2881-2886. (Pubitemid 350035679)
19. Baldassarre D, De Jong A, Amato M, Werba JP, Castelnuovo S, Frigerio B, Veglia F, Tremoli E, Sirtori CR. Carotid intima-media thickness and markers of inflammation, endothelial damage and hemostasis. Ann Med. 2008;40:21-44. (Pubitemid 351197923)
20. Ahluwalia N, Drouet L, Ruidavets JB, Perret B, Amar J, Boccalon H, Hanaire-Broutin H, Ferrires J. Metabolic syndrome is associated with markers of subclinical atherosclerosis in a French population-based sample. Atherosclerosis. 2006;186:345-353.
21. Koskinen J, Kähönen M, Viikari JS, Taittonen L, Laitinen T, Rönnemaa T, Lehtimäki T, Hutri-Kähönen N, Pietikäinen M, Jokinen E, Helenius H, Mattsson N, Raitakari OT, Juonala M. Conventional cardiovascular risk factors and metabolic syndrome in predicting carotid intima-media thickness progression in young adults: The cardiovascular risk in young Finns study. Circulation. 2009;120:229-236.
22. Ridker PM, Buring JE, Cook NR, Rifai N. C-reactive protein, the metabolic syndrome, and risk of incident cardiovascular events: An 8-year follow-up of 14 719 initially healthy American women. Circulation. 2003;107:391-397.
23. Alberti KG, Eckel RH, Grundy SM, Zimmet PZ, Cleeman JI, Donato KA, Fruchart JC, James WP, Loria CM, Smith SC Jr; International Diabetes Federation Task Force on Epidemiology and Prevention; Hational Heart, Lung, and Blood Institute; American Heart Association; World Heart Federation; International Atherosclerosis Society; International Association for the Study of Obesity. Harmonizing the metabolic syndrome: A joint interim statement of the International Diabetes Federation Task Force on Epidemiology and Prevention; National Heart, Lung, and Blood Institute; American Heart Association; World Heart Federation; International Atherosclerosis Society; and International Association for the Study of Obesity. Circulation. 2009;120: 1640-1645.
24. Bots ML, Hoes AW, Koudstaal PJ, Hofman A, Grobbee DE. Common carotid intima-media thickness and risk of stroke and myocardial nfarction: The Rotterdam Study. Circulation. 1997;96:1432-1437. (Pubitemid 27375333)
25. del Sol AI, Moons KG, Hollander M, Hofman A, Koudstaal PJ, Grobbee DE, Breteler MM, Witteman JC, Bots ML. Is carotid intima-media thickness useful in cardiovascular disease risk assessment? The Rotterdam Study. Stroke. 2001;32:1532-1538. (Pubitemid 32631901)
26. Willeit J, Kiechl S, Oberhollenzer F, Rungger G, Egger G, Bonora E, Mitterer M, Muggeo M. Distinct risk profiles of early and advanced atherosclerosis: Prospective results from the Bruneck Study. Arterioscler Thromb Vasc Biol. 2000;20:529-537. (Pubitemid 30086113)
27. Spence JD. Technology Insight: Ultrasound measurement of carotid plaque-patient management, genetic research, and therapy evaluation. Nat Clin Pract Neurol. 2006;2:611-619. (Pubitemid 44614087)
28. Johnsen SH, Mathiesen EB. Carotid plaque compared with intima-media thickness as a predictor of coronary and cerebrovascular disease. Curr Cardiol Rep. 2009;11:21-27.
29. Pollex RL, Al-Shali KZ, House AA, Spence JD, Fenster A, Mamakeesick M, Zinman B, Harris SB, Hanley AJ, Hegele RA. Relationship of the metabolic syndrome to carotid ultrasound traits. Cardiovasc Ultrasound. 2006;4:28.
30. Ishizaka N, Ishizaka Y, Hashimoto H, Toda E, Nagai R, Yamakado M. Metabolic syndrome may not associate with carotid plaque in subjects with optimal, normal, or high-normal blood pressure. Hypertension. 2006;48:411-417. (Pubitemid 44253734)
31. Chen PC, Chien KL, Hsu HC, Su TC, Chang CW, Sung FC, Lee YT. C-reactive protein and the metabolic syndrome correlate differently with carotid atherosclerosis between men and women in a Taiwanese community. Metab Clin Exp. 2008;57:1023-1028.
32. Kalish GM, Barrett-Connor E, Laughlin GA, Gulanski BI; Postmenopausal Estrogen/Progestin Intervention Trial. Association of endogenous sex hormones and insulin resistance among postmenopausal women: Results from the Postmenopausal Estrogen/ Progestin Intervention Trial. J Clin Endocrinol Metab. 2003;88: 1646-1652. (Pubitemid 36623382)
33. Jiang CQ, Xu L, Lam TH, Lin JM, Cheng KK, Thomas GN. Smoking cessation and carotid atherosclerosis: The Guangzhou Biobank Cohort Study-CVD. J Epidemiol Community Health. 2010;64: 1004-1009.
34. Amarenco P, Labreuche J, Touboul PJ. High-density lipoprotein-cholesterol and risk of stroke and carotid atherosclerosis: A systematic review. Atherosclerosis. 2008;196:489-496. (Pubitemid 351146660)